Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

This study aimed to assess serum 25-hydroxyvitamin D [25(OH)D] levels in Ethiopian women newly diagnosed with BC compared to healthy controls.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

A comparative cross-sectional study was conducted from January to March 2024 at Tikur Anbessa Specialized Hospital, Addis Ababa.

Source: Abstract.

A total of 138 participants were enrolled, with 69 in each group.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Serum 25-hydroxyvitamin D levels among women newly diagnosed with breast cancer at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia

Cross-sectional study · BMC Women's Health · 2026

Original publication title

Serum 25-hydroxyvitamin D levels among women newly diagnosed with breast cancer at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia

Mehari Meles; Gadissa Gutema; Melaku Tsegaye; Chala Bashea; Feyissa Challa; Demiraw Bikila; Gebremedhin Gebremicael; Tigst Getahun; Wossene Habtu; Mekdes Alem; Abebe Edao; Anna Carobene; Habteyes Hailu Tola

© The Author(s) 2026

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

SVDD and higher Body Mass Index were significantly associated with BC status. Lower 25(OH)D levels are most pronounced in metastatic (Stage IV) disease. While reduced sunlight exposure was also associated with BC, the direction of these relationships cannot be determined with certainty. These findings highlight an association that warrants further investigation. Further prospective studies with pre-diagnostic 25(OH)D measurements are needed to clarify causality and to determine whether strategies to address VDD may contribute to BC risk reduction.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Breast cancer (BC) is among the most frequently diagnosed cancers in women, accounting for approximately one in ten new cancer cases annually. The relationship between vitamin D status and BC risk remains unclear; while some observational studies suggest an association, others show no link, and causality is unproven. However, data from sub-Saharan Africa, and specifically Ethiopia, are scarce. This study aimed to assess serum 25-hydroxyvitamin D [25(OH)D] levels in Ethiopian women newly diagnosed with BC compared to healthy controls.

Source: Background

Abstract: What methods does the paper describe?

A comparative cross-sectional study was conducted from January to March 2024 at Tikur Anbessa Specialized Hospital, Addis Ababa. Sixty-nine women with newly diagnosed BC and sixty-nine healthy controls were enrolled. Serum 25(OH)D concentrations were measured via electrochemiluminescence immunoassay. Data analysis was performed with SPSS v20. Median differences were evaluated using the Mann: Whitney U test with Hodges: Lehmann estimates and 95% confidence intervals (CI). Logistic regression identified factors associated with BC, and sensitivity analyses were conducted using alternative clinical cut-offs for severe vitamin D deficiency (SVDD).

Source: Methods

Abstract: Results

Vitamin D deficiency was prevalent in both groups; however, SVDD (< 10 ng/mL) was significantly more prevalent among BC patients than among controls (26.1% vs. 7.2%, p = 0.006). A significant median difference in 25(OH) D levels was observed between cases and controls (median difference: 2.1 ng/mL; 95% CI: 0.07 to 4.4; p = 0.043). Serum 25(OH)D levels were also significantly lower in stage IV BC compared with controls and stage I. SVDD was independently associated with BC (adjusted odds ratio = 7.1; 95% CI: 1.7 to 30.1), and this association remained robust when alternative clinical cut-offs were applied.

Reduced sunlight exposure and overweight/obesity were also independently associated with BC.

Source: Results

Abstract: Conclusion

SVDD and higher Body Mass Index were significantly associated with BC status. Lower 25(OH)D levels are most pronounced in metastatic (Stage IV) disease. While reduced sunlight exposure was also associated with BC, the direction of these relationships cannot be determined with certainty. These findings highlight an association that warrants further investigation. Further prospective studies with pre-diagnostic 25(OH)D measurements are needed to clarify causality and to determine whether strategies to address VDD may contribute to BC risk reduction.

Source: Conclusion
Authors’ abstract

Background

Breast cancer (BC) is among the most frequently diagnosed cancers in women, accounting for approximately one in ten new cancer cases annually. The relationship between vitamin D status and BC risk remains unclear; while some observational studies suggest an association, others show no link, and causality is unproven. However, data from sub-Saharan Africa, and specifically Ethiopia, are scarce. This study aimed to assess serum 25-hydroxyvitamin D [25(OH)D] levels in Ethiopian women newly diagnosed with BC compared to healthy controls.

Methods

A comparative cross-sectional study was conducted from January to March 2024 at Tikur Anbessa Specialized Hospital, Addis Ababa. Sixty-nine women with newly diagnosed BC and sixty-nine healthy controls were enrolled. Serum 25(OH)D concentrations were measured via electrochemiluminescence immunoassay. Data analysis was performed with SPSS v20. Median differences were evaluated using the Mann: Whitney U test with Hodges: Lehmann estimates and 95% confidence intervals (CI). Logistic regression identified factors associated with BC, and sensitivity analyses were conducted using alternative clinical cut-offs for severe vitamin D deficiency (SVDD).

Results

Vitamin D deficiency was prevalent in both groups; however, SVDD (< 10 ng/mL) was significantly more prevalent among BC patients than among controls (26.1% vs. 7.2%, p = 0.006). A significant median difference in 25(OH) D levels was observed between cases and controls (median difference: 2.1 ng/mL; 95% CI: 0.07 to 4.4; p = 0.043). Serum 25(OH)D levels were also significantly lower in stage IV BC compared with controls and stage I. SVDD was independently associated with BC (adjusted odds ratio = 7.1; 95% CI: 1.7 to 30.1), and this association remained robust when alternative clinical cut-offs were applied.

Reduced sunlight exposure and overweight/obesity were also independently associated with BC.

Conclusion

SVDD and higher Body Mass Index were significantly associated with BC status. Lower 25(OH)D levels are most pronounced in metastatic (Stage IV) disease. While reduced sunlight exposure was also associated with BC, the direction of these relationships cannot be determined with certainty. These findings highlight an association that warrants further investigation. Further prospective studies with pre-diagnostic 25(OH)D measurements are needed to clarify causality and to determine whether strategies to address VDD may contribute to BC risk reduction.

Publication and source details

Original title: Serum 25-hydroxyvitamin D levels among women newly diagnosed with breast cancer at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia

Mehari Meles; Gadissa Gutema; Melaku Tsegaye; Chala Bashea; Feyissa Challa; Demiraw Bikila; Gebremedhin Gebremicael; Tigst Getahun; Wossene Habtu; Mekdes Alem; Abebe Edao; Anna Carobene; Habteyes Hailu Tola

BMC Women's Health · 2026

© The Author(s) 20262026https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T16:27:13.870709+00:00

DOI: 10.1186/s12905-026-04453-8 · PMC13217863